Seeking Alpha
04 Sept 2026, 22:19 UTC · 2w ago
Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer Transcript
Verdict
Headline takes no side. We score KZIA +0.20 — slightly bullish.
- Expected · KZIA
+0.20slightly bullish
−1 bearish0bullish +1More positive than 51% of ticker scores this week


